Job responsibilities:
- Develop and execute comprehensive regulatory strategies for ANDA/ NDA submissions, ensuring alignment with FDA requirements under 505(j)/ 505(b)(2) pathways.
- Lead preparation, review of regulatory submissions to US FDA in a dynamic and fast-paced environment.
- Devise strategy and draft/review Controlled Correspondences and Meeting Packages like Pre-IND, ANDA Product Development, Enhanced Mid Cycle Review and Post CRL with limited supervision.
- Develop responses to FDA queries (Filing review, IRs, DRLs, and CRLs) and ensure timely submission of amendments and supplements.
- Manage post-approval CMC activities, including the preparation and submission of supplements (CBE-0, CBE-30, PAS) and annual reports.
- Provide regulatory oversight for CMC-related updates, review, and provide change control assessments as required.
- Provide regulatory guidance to cross-functional teams on product development, manufacturing, testing, and commercialization of various complex drug products and dosage forms.
- Establish and maintain effective internal and cross-functional team communications, i.e., provide regular feedback and communicate work challenges/issues and successes.
- Oversee development and review of product labeling, including prescribing information, carton/container labeling, and patient information leaflets, ensuring compliance with FDA regulations (21 CFR Part 201), PLR/PLLR formatting requirements, and all applicable labeling guidance’s.
- Oversee the end-to-end preparation, compilation, and lifecycle management of regulatory submissions in Electronic Common Technical Document (eCTD) format, ensuring full compliance with FDA eCTD Technical Conformance Guide and regional specifications.
- Ensure submission content across Modules 1 through 5 adheres to formatting and technical requirements, including correct use of metadata and compliance with Study Tagging File (STF) standards for clinical and nonclinical study data.
- Independently submit eCTD submissions via the FDA ESG NextGen portal, including access and user role administration.
Qualifications and Experience:
- Applicant must have a Master’s degree (or US Equivalent) in Pharmaceutical Regulatory Affairs, Pharmacy, Chemistry or related field.
- Three (3) years’ experience in regulatory affairs with a focus on USFDA and complex generics.
- Experience in compiling high-quality marketing authorization applications (505 (b)(2) NDAs and ANDAs). Experience in overseeing labelling and publishing eCTD product dossier compilation.
- Extensive knowledge of U.S. regulatory frameworks, including FDA regulations and ICH guidelines.
- Hands-on work experience on eCTD Modules 1, 2, 3, and 5.
- Hands on experience end-to-end preparation, compilation, and lifecycle management of regulatory submissions in Electronic Common Technical Document (eCTD) format.
- Experience in post-approval CMC activities, including the preparation and submission of supplements (CBE-0, CBE-30, PAS) and annual reports.
- Must have experience with the following: Electronic publishing, structured product labeling, change controls, establishment registrations, and self-identifications.
- Applicants must have expertise across a diverse dosage form including solid orals, injectables and drug device combination products.
40 hours per week, M-F, 9am – 5pm. Must have proof of legal authority to working the United States. $179,296.00 to $182,296.00 per year.
To be considered, please visit RiconPharma LLC’s, an Ingenus Pharmaceuticals affiliate, career site website at https://www.ingenus.com/careers/ and apply by emailing your resume to hr@ingenus.com. Job Number: 32026
To apply for this job email your details to hr@ingenus.com
